Tears may hold key to early Alzheimer's diagnosis
NCT ID NCT06661564
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to find out if proteins and fats in tears can be used to diagnose Alzheimer's disease. Researchers will collect tear samples from 90 participants (people with Alzheimer's and healthy volunteers) and compare the levels of certain biomarkers. If successful, this could lead to a simple, painless eye test instead of a spinal tap.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHRU de Tours
RECRUITINGTours, France, 37044, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple questionnaire empower dementia caregivers after hospital stays?
- Could your heart hold the key to Alzheimer's prevention?
- Can a nudge in your chart unlock Life-Saving genetic clues?
- Can a Voice-Based app map healthy brain aging across 80 years?
- Can MRI reveal the Brain's response to deep brain stimulation?
- Can brain scans and gut bacteria reveal Alzheimer's secrets?